Nicolas Janus
Leo Pharma (Australia)(AU)Leo Pharma (France)(FR)
Publications by Year
Research Areas
Pharmacological Effects and Toxicity Studies, Renal cell carcinoma treatment, Chemotherapy-induced organ toxicity mitigation, Multiple and Secondary Primary Cancers, Renal and Vascular Pathologies
Most-Cited Works
- → Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management(2007)452 cited
- → Recurrent chimeric fusion RNAs in non-cancer tissues and cells(2016)209 cited
- → Cancer and renal insufficiency results of the BIRMA study(2010)193 cited
- → Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients(2010)164 cited
- → Renal Safety of Gadolinium-based Contrast Media in Patients with Chronic Renal Insufficiency(2009)147 cited
- → Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study(2007)107 cited
- → Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study(2011)101 cited
- → Vaccination and chronic kidney disease(2007)83 cited
- → Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study(2012)83 cited
- → Renal insufficiency and cancer treatments(2016)82 cited